The Manufacturers Life Insurance Company Buys New Position in Philip Morris International Inc. $PM

Key Points

• The Manufacturers Life Insurance Company acquired 1.01 million Philip Morris shares worth approximately $183 million, giving it a 0.06% stake. Institutional investors collectively own 78.63% of the company.
• Philip Morris reported strong second-quarter results, with revenue up 10.4% year over year to $11.19 billion and adjusted EPS of $2.20, exceeding the $2.05 consensus estimate.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $205.89. The FDA’s authorization of 11 ZYN ULTRA nicotine pouch products further supports the company’s smoke-free growth strategy.

The Manufacturers Life Insurance Company bought a new stake in Philip Morris International Inc. (NYSE:PM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 1,011,377 shares of the company's stock, valued at approximately $182,968,000. The Manufacturers Life Insurance Company owned approximately 0.06% of Philip Morris International at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Kelly Lawrence W & Associates Inc. CA acquired a new stake in shares of Philip Morris International during the second quarter worth about $34,000. Trajan Wealth LLC acquired a new position in shares of Philip Morris International in the second quarter valued at approximately $35,107,000. Van Hulzen Asset Management LLC purchased a new stake in Philip Morris International during the 2nd quarter worth approximately $1,029,000. Veratis Advisors Inc. purchased a new stake in Philip Morris International during the 2nd quarter worth approximately $348,000. Finally, Paradigm Capital Management LLC NV purchased a new stake in Philip Morris International during the 2nd quarter worth approximately $1,100,000. 78.63% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on PM shares. Barclays raised their price target on shares of Philip Morris International from $205.00 to $225.00 and gave the company an "overweight" rating in a research report on Wednesday, July 29th. BTIG Research set a $221.00 price objective on Philip Morris International and gave the stock a "buy" rating in a research report on Friday, July 24th. Bank of America reiterated a "buy" rating on shares of Philip Morris International in a research note on Thursday, May 21st. Citigroup lifted their target price on Philip Morris International from $210.00 to $225.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Finally, UBS Group boosted their target price on Philip Morris International from $168.00 to $182.00 and gave the stock a "neutral" rating in a research note on Thursday, July 2nd. Ten equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $205.89.

Philip Morris International News Summary

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: The FDA granted Marketing Granted Orders for 11 ZYN ULTRA nicotine pouch products in the United States, including all 9mg variants and one 11mg variant. The authorization broadens PM’s smoke-free portfolio, supports regulatory certainty for ZYN, and reinforces the company’s long-term shift away from combustible tobacco. Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
• Positive Sentiment: Recent second-quarter results provided additional support for the stock: revenue increased 10.4% year over year to $11.19 billion, while adjusted earnings of $2.20 per share exceeded the $2.05 consensus estimate. The company also issued third-quarter earnings guidance of $2.20 to $2.25 per share. Should Strong Q2 Results And New FDA-Authorized ZYN ULTRA Pouches Require Action From Philip Morris Investors?
• Neutral Sentiment: PM and Altria Group NYSE: MO entered reciprocal contract manufacturing agreements intended to improve manufacturing efficiency and operational flexibility. PM’s non-U.S. affiliates will manufacture certain combustible cigarettes for Philip Morris USA, while the arrangements also provide reciprocal production capabilities. First shipments are expected in 2027, and the companies said the agreements should not materially affect 2026 results, limiting the near-term earnings impact. Altria, Philip Morris International sign contract manufacturing deals

Philip Morris International Stock Up 1.7%

Shares of NYSE:PM opened at $191.48 on Tuesday. Philip Morris International Inc. has a fifty-two week low of $142.11 and a fifty-two week high of $207.76. The firm's 50 day moving average price is $186.22 and its 200 day moving average price is $178.46. The stock has a market cap of $298.44 billion, a price-to-earnings ratio of 27.51, a price-to-earnings-growth ratio of 2.27 and a beta of 0.38.

Philip Morris International (NYSE:PM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 EPS for the quarter, topping the consensus estimate of $2.05 by $0.15. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The company had revenue of $11.19 billion during the quarter, compared to analysts' expectations of $10.60 billion. During the same quarter in the previous year, the business posted $1.89 EPS. The firm's revenue was up 10.4% on a year-over-year basis. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities analysts anticipate that Philip Morris International Inc. will post 8.33 EPS for the current year.

Philip Morris International Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Thursday, June 25th were given a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International's payout ratio is 84.48%.

About Philip Morris International

Philip Morris International Inc NYSE: PM is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI's product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source